Search Results - "ACITO, L"

V.02.13 METASTATIC MELANOMA OF THE GALLBLADDER DIAGNOSED BY ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE BIOPSY by Antonini, F, Acito, L, Sisti, S, Angelelli, L, Belfiori, V, De Minicis, S, Lo Cascio, M, Marraccini, B, Piergallini, S, Rossetti, P, Andrenacci, E, Macarri, G

Get full text

Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: a prospective randomized study by Cocconi, G, Passalacqua, R, Foladore, S, Carlini, P, Acito, L, Maiello, E, Marchi, M, Gebbia, V, Di Sarra, S, Beretta, M, Bacchi, M

“…This study aimed to verify whether the advantage in terms of response rate and survival of dacarbazine plus tamoxifen over dacarbazine alone in metastatic…”
Get full text

A double blind randomized study of oral clodronate in the treatment of bone metastases from tumors poorly responsive to chemotherapy by Piga, A, Bracci, R, Ferretti, B, Sandri, P, Nortilli, R, Acito, L, Pancotti, A, Di Furia, L, Carle, F, Cellerino, R

“…Bisphosphonates are used in oncology as a means of decreasing complications due to bone metastases, in association with anticancer treatment, especially in…”
Get more information

A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer by PIGA, A, CASCINU, S, ROSSI, G, DEL PAPA, M, CARLE, F, CELLERINO, R, LATINI, L, MARCELLINI, M, BAVOSI, M, ACITO, L, BASCIONI, R, GIUSTINI, L, FRANCINI, G, PANCOTTI, A

“…With the association of 5-fluorouracil (5-FU) and alpha-interferon (IFN), objective responses as high as 26 63% have been reported in untreated patients with…”
Get full text

Granisetron plus dexamethasone in moderately emetogenic chemotherapy : evaluation of activity during three consecutive courses of chemotherapy by SILVA, R. R, BASCIONI, R, GIORGI, F, ACITO, L, GIUSTINI, L, DE SIGNORIBUS, G, MARCELLINI, M, MENICHETTI, E. T, GIULIODORI, L

“…In this study we evaluated the antiemetic activity of a combination of 3 mg granisetron in a short i.v. infusion followed by 12 mg dexamethasone i.v. in 64…”
Get full text

High-dose folinic acid and fluorouracil with or without ifosfamide is an inactive combination in advanced pancreatic cancer : A randomized phase II study of the Italian Oncology Group for Clinical Research (G.O.I.R.C.) by DI COSTANZO, F, TAGLIAVENTI, M, CARLINI, P, ZIRONI, S, MAZZOCCHI, B, BELLA, M, DONATI, D, ACITO, L, MAGGIAN, P, ANGIONA, S

“…The Italian Oncology Group for Clinical Research (GOIRC) randomized 55 naive patients with advanced pancreatic cancer (APC) between intravenous fluorouracil…”
Get full text

Continuity of care for cancer patients at the end of life (EoL) by Bascioni, R., Esperide, B., Iacopini, D., Basirat, F., Rastelli, F., Acito, L., Bisonni, R., Giustini, L., Giorgi, F.

“…Abstract only…”
Get full text

Paclitaxel and Mitoxantrone in Metastatic Breast Cancer: A Phase II Trial of the Italian Oncology Group for Cancer Research by Di Costanzo, Francesco, Manzione, Luigi, Gasperoni, Silvia, Bilancia, Domenico, Acito, Luigi, Angiona, Sabrina, Mazzoni, Francesca, Giustini, Lucio

“…Background: In a previous dose-finding trial, in previously treated patients with metastatic breast cancer (MBC), we showed that the combination of…”
Get full text

Awareness of disease among Italian cancer patients : Is there a need for further improvement in patient information?

Get full text

Comparison of CMF (cyclophosphamide, methotrexate, and 5-fluorouracil) with a rotational crossing and a sequential intensification regimen in advanced breast cancer a prospective randomized study by COCCONI, G, BISAGNI, G, BUZZI, P, BELLA, M, ACITO, L, ANASTASI, P, CARPI, A, DI COSTANZO, F, FRASSOLDATI, A, MOSCONI, A, BORRINI, A

“…The Italian Oncology Group for Clinical Research tested two experimental chemotherapy strategies in an attempt to improve the results achievable with…”
Get full text

PP-7-13 Phase I–II trial of mitoxantrone (M) and taxot (T) in advanced breast cancer (ABC) by Costanzo, F.Di, Sdrobolini, A., Bilancia, D., Farabi, R., Angiona, S., Gasperoni, S., Bartolucci, R., Giustini, L., Acito, L., Manzione, L

Get full text

Dose intensification of mitoxantrone in combination with paclitaxel in advanced breast cancer : a phase II study by DI COSTANZO, F, SDROBOLINI, A, MANZIONE, L, BILANCIA, D, ACITO, L, GASPERONI, S, VALENTI, L, FIORITI, L, ANGIONA, S, GIUSTINI, L

“…Paclitaxel and mitoxantrone are highly active agents in the treatment of advanced breast cancer (ABC). This study evaluated the combination of paclitaxel and…”
Get full text

Phase I-II trial of mitoxantrone (M) and taxol (T) in advanced breast cancer by Guistini, L., Di Costanzo, F., Sdrobolini, A., Bilancia, D., Valenti, L., Angiona, S., Gasperoni, S., Bartolucci, R., Acito, L., Manzione, L.

Get full text

Mitoxantrone, fluorouracil, and L-folinic acid in anthracycline-pretreated metastatic breast cancer patients by BASCIONI, R, GIORGI, F, SILVA, R. R, ACITO, L, GIUSTINI, L, DE SIGNORIBUS, G, GIULIODORI, L, TESTA, E

“…In this phase II trial we have evaluated the activity and toxicity of a combination regimen containing mitoxantrone, L-leucovorin, and fluorouracil in patients…”
Get full text